Selected research
Market Analysis & Forecast
Global Airsickness Treatment Drug Market Analysis and Forecast 2026-2032
Market perspective
The global Airsickness Treatment Drug market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Airsickness Treatment Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for Airsickness Treatment Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for Airsickness Treatment Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for Airsickness Treatment Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global manufacturers of Airsickness Treatment Drug include Sandoz, Mylan, Pfizer, GlaxoSmithKline, Baxter International, WellSpring Pharmaceutical Corporation, Prestige Brands, Myungmoon Pharm and Caleb Pharmaceuticals, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Airsickness Treatment Drug, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Airsickness Treatment Drug, also provides the sales of main regions and countries. Of the upcoming market potential for Airsickness Treatment Drug, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Airsickness Treatment Drug sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Airsickness Treatment Drug market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Airsickness Treatment Drug sales, projected growth trends, production technology, application and end-user industry.
Airsickness Treatment Drug Segment by Company
Sandoz
Mylan
Pfizer
GlaxoSmithKline
Baxter International
WellSpring Pharmaceutical Corporation
Prestige Brands
Myungmoon Pharm
Caleb Pharmaceuticals
Airsickness Treatment Drug Segment by Type
Anticholinergic
Antihistamines
Airsickness Treatment Drug Segment by Application
Adults
Children
Airsickness Treatment Drug Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Airsickness Treatment Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Airsickness Treatment Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Airsickness Treatment Drug.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Airsickness Treatment Drug in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Airsickness Treatment Drug manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Airsickness Treatment Drug sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Anticholinergic
- Antihistamines
Applications
- Adults
- Children
Companies covered
- Sandoz
- Mylan
- Pfizer
- GlaxoSmithKline
- Baxter International
- WellSpring Pharmaceutical Corporation
- Prestige Brands
- Myungmoon Pharm
- Caleb Pharmaceuticals
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Airsickness Treatment Drug Market by Type
- 1.2.1 Global Airsickness Treatment Drug Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 Anticholinergic
- 1.2.3 Antihistamines
- 1.3 Airsickness Treatment Drug Market by Application
- 1.3.1 Global Airsickness Treatment Drug Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Adults
- 1.3.3 Children
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Airsickness Treatment Drug Market Dynamics
- 2.1 Airsickness Treatment Drug Industry Trends
- 2.2 Airsickness Treatment Drug Industry Drivers
- 2.3 Airsickness Treatment Drug Industry Opportunities and Challenges
- 2.4 Airsickness Treatment Drug Industry Restraints
3 Global Market Growth Prospects
- 3.1 Global Airsickness Treatment Drug Revenue Estimates and Forecasts (2021-2032)
- 3.2 Global Airsickness Treatment Drug Revenue by Region
- 3.2.1 Global Airsickness Treatment Drug Revenue by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Airsickness Treatment Drug Revenue by Region (2021-2026)
- 3.2.3 Global Airsickness Treatment Drug Revenue by Region (2027-2032)
- 3.2.4 Global Airsickness Treatment Drug Revenue Market Share by Region (2021-2032)
- 3.3 Global Airsickness Treatment Drug Sales Estimates and Forecasts 2021-2032
- 3.4 Global Airsickness Treatment Drug Sales by Region
- 3.4.1 Global Airsickness Treatment Drug Sales by Region: 2021 VS 2025 VS 2032
- 3.4.2 Global Airsickness Treatment Drug Sales by Region (2021-2026)
- 3.4.3 Global Airsickness Treatment Drug Sales by Region (2027-2032)
- 3.4.4 Global Airsickness Treatment Drug Sales Market Share by Region (2021-2032)
- 3.5 US & Canada & Mexico
- 3.6 Europe
- 3.7 China
- 3.8 Asia (Excluding China)
- 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
- 4.1 Global Airsickness Treatment Drug Revenue by Manufacturers
- 4.1.1 Global Airsickness Treatment Drug Revenue by Manufacturers (2021-2026)
- 4.1.2 Global Airsickness Treatment Drug Revenue Market Share by Manufacturers (2021-2026)
- 4.1.3 Global Airsickness Treatment Drug Manufacturers Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Airsickness Treatment Drug Sales by Manufacturers
- 4.2.1 Global Airsickness Treatment Drug Sales by Manufacturers (2021-2026)
- 4.2.2 Global Airsickness Treatment Drug Sales Market Share by Manufacturers (2021-2026)
- 4.2.3 Global Airsickness Treatment Drug Manufacturers Sales Share Top 10 and Top 5 in 2025
- 4.3 Global Airsickness Treatment Drug Sales Price by Manufacturers (2021-2026)
- 4.4 Global Airsickness Treatment Drug Key Manufacturers Ranking, 2024 VS 2025 VS 2026
- 4.5 Global Airsickness Treatment Drug Key Manufacturers Manufacturing Sites & Headquarters
- 4.6 Global Airsickness Treatment Drug Manufacturers, Product Type & Application
- 4.7 Global Airsickness Treatment Drug Manufacturers' Establishment Date
- 4.8 Market Competitive Analysis
- 4.8.1 Global Airsickness Treatment Drug Market CR5 and HHI
- 4.8.2 2025 Airsickness Treatment Drug Tier 1, Tier 2, and Tier 3
5 Airsickness Treatment Drug Market by Type
- 5.1 Global Airsickness Treatment Drug Revenue by Type
- 5.1.1 Global Airsickness Treatment Drug Revenue by Type (2021 VS 2025 VS 2032)
- 5.1.2 Global Airsickness Treatment Drug Revenue by Type (2021-2032) & (US$ Million)
- 5.1.3 Global Airsickness Treatment Drug Revenue Market Share by Type (2021-2032)
- 5.2 Global Airsickness Treatment Drug Sales by Type
- 5.2.1 Global Airsickness Treatment Drug Sales by Type (2021 VS 2025 VS 2032)
- 5.2.2 Global Airsickness Treatment Drug Sales by Type (2021-2032) & (k units)
- 5.2.3 Global Airsickness Treatment Drug Sales Market Share by Type (2021-2032)
- 5.3 Global Airsickness Treatment Drug Price by Type
6 Airsickness Treatment Drug Market by Application
- 6.1 Global Airsickness Treatment Drug Revenue by Application
- 6.1.1 Global Airsickness Treatment Drug Revenue by Application (2021 VS 2025 VS 2032)
- 6.1.2 Global Airsickness Treatment Drug Revenue by Application (2021-2032) & (US$ Million)
- 6.1.3 Global Airsickness Treatment Drug Revenue Market Share by Application (2021-2032)
- 6.2 Global Airsickness Treatment Drug Sales by Application
- 6.2.1 Global Airsickness Treatment Drug Sales by Application (2021 VS 2025 VS 2032)
- 6.2.2 Global Airsickness Treatment Drug Sales by Application (2021-2032) & (k units)
- 6.2.3 Global Airsickness Treatment Drug Sales Market Share by Application (2021-2032)
- 6.3 Global Airsickness Treatment Drug Price by Application
7 Company Profiles
- 7.1 Sandoz
- 7.1.1 Sandoz Company Information
- 7.1.2 Sandoz Business Overview
- 7.1.3 Sandoz Airsickness Treatment Drug Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.1.4 Sandoz Airsickness Treatment Drug Product Portfolio
- 7.1.5 Sandoz Recent Developments
- 7.2 Mylan
- 7.2.1 Mylan Company Information
- 7.2.2 Mylan Business Overview
- 7.2.3 Mylan Airsickness Treatment Drug Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.2.4 Mylan Airsickness Treatment Drug Product Portfolio
- 7.2.5 Mylan Recent Developments
- 7.3 Pfizer
- 7.3.1 Pfizer Company Information
- 7.3.2 Pfizer Business Overview
- 7.3.3 Pfizer Airsickness Treatment Drug Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.3.4 Pfizer Airsickness Treatment Drug Product Portfolio
- 7.3.5 Pfizer Recent Developments
- 7.4 GlaxoSmithKline
- 7.4.1 GlaxoSmithKline Company Information
- 7.4.2 GlaxoSmithKline Business Overview
- 7.4.3 GlaxoSmithKline Airsickness Treatment Drug Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.4.4 GlaxoSmithKline Airsickness Treatment Drug Product Portfolio
- 7.4.5 GlaxoSmithKline Recent Developments
- 7.5 Baxter International
- 7.5.1 Baxter International Company Information
- 7.5.2 Baxter International Business Overview
- 7.5.3 Baxter International Airsickness Treatment Drug Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.5.4 Baxter International Airsickness Treatment Drug Product Portfolio
- 7.5.5 Baxter International Recent Developments
- 7.6 WellSpring Pharmaceutical Corporation
- 7.6.1 WellSpring Pharmaceutical Corporation Company Information
- 7.6.2 WellSpring Pharmaceutical Corporation Business Overview
- 7.6.3 WellSpring Pharmaceutical Corporation Airsickness Treatment Drug Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.6.4 WellSpring Pharmaceutical Corporation Airsickness Treatment Drug Product Portfolio
- 7.6.5 WellSpring Pharmaceutical Corporation Recent Developments
- 7.7 Prestige Brands
- 7.7.1 Prestige Brands Company Information
- 7.7.2 Prestige Brands Business Overview
- 7.7.3 Prestige Brands Airsickness Treatment Drug Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.7.4 Prestige Brands Airsickness Treatment Drug Product Portfolio
- 7.7.5 Prestige Brands Recent Developments
- 7.8 Myungmoon Pharm
- 7.8.1 Myungmoon Pharm Company Information
- 7.8.2 Myungmoon Pharm Business Overview
- 7.8.3 Myungmoon Pharm Airsickness Treatment Drug Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.8.4 Myungmoon Pharm Airsickness Treatment Drug Product Portfolio
- 7.8.5 Myungmoon Pharm Recent Developments
- 7.9 Caleb Pharmaceuticals
- 7.9.1 Caleb Pharmaceuticals Company Information
- 7.9.2 Caleb Pharmaceuticals Business Overview
- 7.9.3 Caleb Pharmaceuticals Airsickness Treatment Drug Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.9.4 Caleb Pharmaceuticals Airsickness Treatment Drug Product Portfolio
- 7.9.5 Caleb Pharmaceuticals Recent Developments
8 North America
- 8.1 North America Airsickness Treatment Drug Market Size by Type
- 8.1.1 North America Airsickness Treatment Drug Revenue by Type (2021-2032)
- 8.1.2 North America Airsickness Treatment Drug Sales by Type (2021-2032)
- 8.1.3 North America Airsickness Treatment Drug Price by Type (2021-2032)
- 8.2 North America Airsickness Treatment Drug Market Size by Application
- 8.2.1 North America Airsickness Treatment Drug Revenue by Application (2021-2032)
- 8.2.2 North America Airsickness Treatment Drug Sales by Application (2021-2032)
- 8.2.3 North America Airsickness Treatment Drug Price by Application (2021-2032)
- 8.3 North America Airsickness Treatment Drug Market Size by Country
- 8.3.1 North America Airsickness Treatment Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 8.3.2 North America Airsickness Treatment Drug Sales by Country (2021 VS 2025 VS 2032)
- 8.3.3 North America Airsickness Treatment Drug Price by Country (2021-2032)
- 8.3.4 United States
- 8.3.5 Canada
- 8.3.6 Mexico
9 Europe
- 9.1 Europe Airsickness Treatment Drug Market Size by Type
- 9.1.1 Europe Airsickness Treatment Drug Revenue by Type (2021-2032)
- 9.1.2 Europe Airsickness Treatment Drug Sales by Type (2021-2032)
- 9.1.3 Europe Airsickness Treatment Drug Price by Type (2021-2032)
- 9.2 Europe Airsickness Treatment Drug Market Size by Application
- 9.2.1 Europe Airsickness Treatment Drug Revenue by Application (2021-2032)
- 9.2.2 Europe Airsickness Treatment Drug Sales by Application (2021-2032)
- 9.2.3 Europe Airsickness Treatment Drug Price by Application (2021-2032)
- 9.3 Europe Airsickness Treatment Drug Market Size by Country
- 9.3.1 Europe Airsickness Treatment Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 9.3.2 Europe Airsickness Treatment Drug Sales by Country (2021 VS 2025 VS 2032)
- 9.3.3 Europe Airsickness Treatment Drug Price by Country (2021-2032)
- 9.3.4 Germany
- 9.3.5 France
- 9.3.6 U.K.
- 9.3.7 Italy
- 9.3.8 Russia
- 9.3.9 Spain
- 9.3.10 Netherlands
10 China
- 10.1 China Airsickness Treatment Drug Market Size by Type
- 10.1.1 China Airsickness Treatment Drug Revenue by Type (2021-2032)
- 10.1.2 China Airsickness Treatment Drug Sales by Type (2021-2032)
- 10.1.3 China Airsickness Treatment Drug Price by Type (2021-2032)
- 10.2 China Airsickness Treatment Drug Market Size by Application
- 10.2.1 China Airsickness Treatment Drug Revenue by Application (2021-2032)
- 10.2.2 China Airsickness Treatment Drug Sales by Application (2021-2032)
- 10.2.3 China Airsickness Treatment Drug Price by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Airsickness Treatment Drug Market Size by Type
- 11.1.1 Asia Airsickness Treatment Drug Revenue by Type (2021-2032)
- 11.1.2 Asia Airsickness Treatment Drug Sales by Type (2021-2032)
- 11.1.3 Asia Airsickness Treatment Drug Price by Type (2021-2032)
- 11.2 Asia Airsickness Treatment Drug Market Size by Application
- 11.2.1 Asia Airsickness Treatment Drug Revenue by Application (2021-2032)
- 11.2.2 Asia Airsickness Treatment Drug Sales by Application (2021-2032)
- 11.2.3 Asia Airsickness Treatment Drug Price by Application (2021-2032)
- 11.3 Asia Airsickness Treatment Drug Market Size by Country
- 11.3.1 Asia Airsickness Treatment Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 11.3.2 Asia Airsickness Treatment Drug Sales by Country (2021 VS 2025 VS 2032)
- 11.3.3 Asia Airsickness Treatment Drug Price by Country (2021-2032)
- 11.3.4 Japan
- 11.3.5 South Korea
- 11.3.6 India
- 11.3.7 Australia
- 11.3.8 Taiwan
- 11.3.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Airsickness Treatment Drug Market Size by Type
- 12.1.1 SAMEA Airsickness Treatment Drug Revenue by Type (2021-2032)
- 12.1.2 SAMEA Airsickness Treatment Drug Sales by Type (2021-2032)
- 12.1.3 SAMEA Airsickness Treatment Drug Price by Type (2021-2032)
- 12.2 SAMEA Airsickness Treatment Drug Market Size by Application
- 12.2.1 SAMEA Airsickness Treatment Drug Revenue by Application (2021-2032)
- 12.2.2 SAMEA Airsickness Treatment Drug Sales by Application (2021-2032)
- 12.2.3 SAMEA Airsickness Treatment Drug Price by Application (2021-2032)
- 12.3 SAMEA Airsickness Treatment Drug Market Size by Country
- 12.3.1 SAMEA Airsickness Treatment Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 12.3.2 SAMEA Airsickness Treatment Drug Sales by Country (2021 VS 2025 VS 2032)
- 12.3.3 SAMEA Airsickness Treatment Drug Price by Country (2021-2032)
- 12.3.4 Brazil
- 12.3.5 Argentina
- 12.3.6 Chile
- 12.3.7 Colombia
- 12.3.8 Peru
- 12.3.9 Saudi Arabia
- 12.3.10 Israel
- 12.3.11 UAE
- 12.3.12 Turkey
- 12.3.13 Iran
- 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
- 13.1 Airsickness Treatment Drug Value Chain Analysis
- 13.1.1 Airsickness Treatment Drug Key Raw Materials
- 13.1.2 Raw Materials Key Suppliers
- 13.1.3 Manufacturing Cost Structure
- 13.1.4 Airsickness Treatment Drug Production Mode & Process
- 13.2 Airsickness Treatment Drug Sales Channels Analysis
- 13.2.1 Direct Comparison with Distribution Share
- 13.2.2 Airsickness Treatment Drug Distributors
- 13.2.3 Airsickness Treatment Drug Customers
14 Concluding Insights
15 Appendix
- 15.1 Reasons for Doing This Study
- 15.2 Research Methodology
- 15.3 Research Process
- 15.4 Authors List of This Report
- 15.5 Data Source
- 15.5.1 Secondary Sources
- 15.5.2 Primary Sources
- 15.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst